Dr. Jonasch on Using the Tumor Microenvironment and Epigenetics as Biomarkers in RCC

Dr. Jonasch on Using the Tumor Microenvironment and Epigenetics as Biomarkers in RCC

Eric Jonasch, MD, on how understanding features within the tumor microenvironment and mutated epigenetic modifying genes may provide insight on prognosis or treatment strategies in renal cell carcinoma. Website: https://www.onclive.com Twitter:   / onclive   Facebook:   / onclive   LinkedIn:   / onclive